The purpose of this paper is to review and possibly match some of the alledged pathophysiological aspects of critical limb ischaemia (CLI) and the properties of vasoactive prostaglandins (PGs) (namely PGE1, and PGI2) likely counteracting them, thus suggesting a therapeutic role of these PGs in CLI.
|Number of pages||9|
|Journal||Agents and Actions|
|Publication status||Published - 1992|
ASJC Scopus subject areas
- Pharmacology (medical)